Cochrane Abstracts
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Angiotensin Converting Enzyme (ACE) Inhibitors Versus Angiotensin Receptor Blockers for Primary Hypertension." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438133/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension. Accessed 08 October 2024.
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438133/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension. Accessed October 8, 2024.
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438133/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension
Angiotensin Converting Enzyme (ACE) Inhibitors Versus Angiotensin Receptor Blockers for Primary Hypertension [Internet]. In: Cochrane Abstracts. [cited 2024 October 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438133/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
ID - 438133
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438133/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension
DB - Evidence Central
DP - Unbound Medicine
ER -
